For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted against the virus that causes COVID-19, according to a study of the antibody response to the Pfizer-BioNTech vaccine by researchers at Washington University School of Medicine in St. Louis.
Antibodies improve in quality for months after COVID-19 vaccination
February 15, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022